Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Liposomal Doxorubicin
The 2025-2030 World Outlook for Liposomal Doxorubicin This study covers the world outlook for liposomal doxorubicin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Neurological Disorder Drugs
The 2025-2030 World Outlook for Neurological Disorder Drugs This study covers the world outlook for neurological disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Nicotine Addiction Therapeutics
The 2025-2030 World Outlook for Nicotine Addiction Therapeutics This study covers the world outlook for nicotine addiction therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Natural Killer Cell Therapeutics
The 2025-2030 World Outlook for Natural Killer Cell Therapeutics This study covers the world outlook for natural killer cell therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Schizophrenia Therapeutics
The 2025-2030 World Outlook for Schizophrenia Therapeutics This study covers the world outlook for schizophrenia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Neuroprotection Therapeutics
The 2025-2030 World Outlook for Neuroprotection Therapeutics This study covers the world outlook for neuroprotection therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Scleroderma Therapeutics
The 2025-2030 World Outlook for Scleroderma Therapeutics This study covers the world outlook for scleroderma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Sepsis Therapeutics
The 2025-2030 World Outlook for Sepsis Therapeutics This study covers the world outlook for sepsis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms This study covers the world outlook for cloud-based drug discovery platforms across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Localized Scleroderma Diagnostics and Therapeutics
The 2025-2030 World Outlook for Localized Scleroderma Diagnostics and Therapeutics This study covers the world outlook for localized scleroderma diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earni ... Read More
-
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics This study covers the world outlook for hormone therapy for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Hospital Infection Therapeutics
The 2025-2030 World Outlook for Hospital Infection Therapeutics This study covers the world outlook for hospital infection therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Schizophrenia Drugs
The 2025-2030 World Outlook for Schizophrenia Drugs This study covers the world outlook for schizophrenia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Lupus Drugs
The 2025-2030 World Outlook for Lupus Drugs This study covers the world outlook for lupus drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2025-2030 World Outlook for Human Microbiome Therapeutics
The 2025-2030 World Outlook for Human Microbiome Therapeutics This study covers the world outlook for human microbiome therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Lysosomal Storage Diseases Therapeutics
The 2025-2030 World Outlook for Lysosomal Storage Diseases Therapeutics This study covers the world outlook for lysosomal storage diseases therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Rabies Treatments
The 2025-2030 World Outlook for Rabies Treatments This study covers the world outlook for rabies treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics This study covers the world outlook for cancer supportive care therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Autism Spectrum Disorder Therapeutics
The 2025-2030 World Outlook for Autism Spectrum Disorder Therapeutics This study covers the world outlook for autism spectrum disorder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Drugs
The 2025-2030 World Outlook for Breast Cancer Drugs This study covers the world outlook for breast cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Progestogens for Cancer Cachexia
The 2025-2030 World Outlook for Progestogens for Cancer Cachexia This study covers the world outlook for progestogens for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Prostate Cancer Therapeutics
The 2025-2030 World Outlook for Prostate Cancer Therapeutics This study covers the world outlook for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Uveitis Drugs
The 2025-2030 World Outlook for Uveitis Drugs This study covers the world outlook for uveitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Drugs
The 2025-2030 World Outlook for Osteoarthritis Drugs This study covers the world outlook for osteoarthritis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Migraine Drugs
The 2025-2030 World Outlook for Migraine Drugs This study covers the world outlook for migraine drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
Research Assistance
